Cesarean delivery is a commonly performed surgical procedure associated with worse postpartum pain when compared to vaginal birth. Uncontrolled postpartum pain is associated with increased neonatal and maternal risks. Multimodal non-opioid pain medications, including acetaminophen and non-steroidal anti-inflammatory drugs (NSAIDs) are the preferred first-line therapies. There is no standard practice, however, on best dosing schedules (ie staggered or different time v. simultaneous or same time). This protocol describes a randomized clinical trial aimed to determine whether staggered dosing of acetaminophen and NSAIDs in superior to simultaneous dosing in controlling post-cesarean pain.
Cesarean delivery is a commonly performed surgical procedure. The rate of cesarean delivery (CD) is increasing in the US; cesarean accounted for 32% of all births in 2022. Parents who deliver via CD experience more pain than those who have a vaginal birth. Uncontrolled postpartum pain can be associated with an increased risk of physical complications including venous thrombosis, atelectasis, pneumonia as well as increased psychological distress. Poor postpartum pain control can also hinder infant-parental bonding and impact breastfeeding initiation or continuation. Multiple strategies for post-operative pain management exist including opioid and non-opioid medications. Multimodal non-opioid medications are preferred as first-line therapies due to the short- and long-term risks associated with opioid pain medication. Acetaminophen and ibuprofen are most commonly utilized in the US. A meta-analysis of 21 studies enrolling 1909 post-operative patients examined the efficacy of NSAIDs and parecetamol in combination compared to each drug alone and found a significant reduction in pain intensity for combination therapy compared to each drug alone. Both acetaminophen and ibuprofen can be given every 6 hours. Practices differ, however, on administering these medications at the same time or in a staggered fashion. To date, there are no trials comparing these different dosing schedules for post-cesarean delivery pain control.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
825
Acetaminophen 1000 mg q6H
NSAID (ketorolac 30 mg q6H for first 24 hours post-op followed by ibuprofen 600 mg q6H)
Thomas Jefferson University Hospital
Philadelphia, Pennsylvania, United States
RECRUITINGPostpartum pain control
Visual analog pain score (VAS) with movement. Scale ranges from 0-10 with 0 indicating no pain and 10 indicating worst possible pain
Time frame: 48 (+/- 2) hours postpartum
Opioid consumption
Opioid consumption (in total morphine milligram equivalents (MME))
Time frame: Postpartum Admission (From time of surgery to hospital discharge; typically 2-5 days)
Postpartum pain at 6 hours
Visual analog pain score with rest. Scale ranges from 0-10 with 0 indicating no pain and 10 indicating worst possible pain
Time frame: 6 hours (+/- 1 hour) post-op
Postpartum pain at 12 hours
Visual analog pain score with rest and movement. Scale ranges from 0-10 with 0 indicating no pain and 10 indicating worst possible pain
Time frame: 12 hours (+/-2 hours) post-op
Postpartum pain at 24 hours
Visual analog pain score with rest and movement. Scale ranges from 0-10 with 0 indicating no pain and 10 indicating worst possible pain
Time frame: 24 hours (+/-2 hours) post-op
Postpartum pain at 48 hours
Visual analog pain score with rest. Scale ranges from 0-10 with 0 indicating no pain and 10 indicating worst possible pain
Time frame: 48 hours (+/- 2 hours) post-op.
Adequate pain control
Adequate pain control (Visual analog score \<4). Scale ranges from 0-10 with 0 indicating no pain and 10 indicating worst possible pain
Time frame: by 48 hours (+/-2 hours) post-op
Length of stay
Duration of hospitalization
Time frame: Admission to discharge (Typically 2-7 days)
Infant feeding
Exclusive breastfeeding, combination feeding, or formula feeding
Time frame: At time of hospital discharge (Typically 1- 5 days post-op)
Patient satisfaction
Patient satisfaction with pain control. Assessed via International Pain Outcomes (IPO) questionnaire. Scores for individual items in this questionnaire range from 0-10, with 0 indicating no symptoms and 10 indicating worst possible symptoms, OR from 0-100% for questions inquiring about time (0% being no time and 100% being all the time).
Time frame: Post-operative day #2-5.
Opioid Prescription
Need for opioid prescription (Yes or No) and amount (MME)
Time frame: At hospital discharge (Post-operative day #2-5)
Home opioid
Home opioid use in the first week postpartum (Assessed by telephone call)
Time frame: Post-operative day #10-14
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.